Total Payments
$106,594
2024 Payments
$551.24
Companies
25
Transactions
136
Medicare Patients
804
Medicare Billing
$230,791
Payment Breakdown by Category
Other$48,426 (45.4%)
Consulting$46,848 (44.0%)
Travel$6,147 (5.8%)
Food & Beverage$4,523 (4.2%)
Research$650.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $46,848 | 23 | 44.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,785 | 18 | 43.9% |
| Travel and Lodging | $6,147 | 24 | 5.8% |
| Food and Beverage | $4,523 | 68 | 4.2% |
| Honoraria | $1,641 | 2 | 1.5% |
| Unspecified | $650.00 | 1 | 0.6% |
Payments by Type
General
$105,944
135 transactions
Research
$650.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kyowa Kirin, Inc. | $33,668 | 34 | $0 (2024) |
| Seattle Genetics, Inc. | $20,233 | 32 | $0 (2019) |
| Kyowa Kirin Services Ltd | $15,313 | 8 | $0 (2023) |
| Mallinckrodt LLC | $11,207 | 12 | $0 (2017) |
| Seagen Inc. | $8,952 | 13 | $0 (2023) |
| Secura Bio, Inc. | $5,652 | 4 | $0 (2024) |
| Acrotech Biopharma Inc. | $4,659 | 3 | $0 (2023) |
| Verastem, Inc. | $2,833 | 3 | $0 (2020) |
| Daiichi Sankyo Inc. | $2,096 | 1 | $0 (2021) |
| BeiGene, Ltd. | $650.00 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $551.24 | 8 | Kyowa Kirin, Inc. ($268.58) |
| 2023 | $15,892 | 22 | Kyowa Kirin Services Ltd ($9,999) |
| 2022 | $14,081 | 16 | Kyowa Kirin, Inc. ($9,154) |
| 2021 | $24,391 | 18 | Kyowa Kirin, Inc. ($16,430) |
| 2020 | $17,675 | 10 | Seagen Inc. ($6,385) |
| 2019 | $7,460 | 15 | Seattle Genetics, Inc. ($7,068) |
| 2018 | $15,221 | 32 | Seattle Genetics, Inc. ($13,128) |
| 2017 | $11,324 | 15 | Mallinckrodt LLC ($11,207) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $138.77 | General |
| Category: Monoclonal Antibody | ||||||
| 10/25/2024 | Secura Bio, Inc. | COPIKTRA (Drug) | Food and Beverage | In-kind items and services | $151.87 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 08/14/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ONCOLOGY | ||||||
| 04/02/2024 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/08/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $93.71 | General |
| Category: Monoclonal Antibody | ||||||
| 03/06/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $78.36 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $36.10 | General |
| Category: Monoclonal Antibody | ||||||
| 12/14/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Consulting Fee | Cash or cash equivalent | $1,637.50 | General |
| Category: Monoclonal Antibody | ||||||
| 12/10/2023 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $18.51 | General |
| 12/09/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $47.81 | General |
| Category: Monoclonal Antibody | ||||||
| 12/08/2023 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $114.63 | General |
| Category: Monoclonal antibody | ||||||
| 12/07/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $73.02 | General |
| Category: Monoclonal antibody | ||||||
| 10/26/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $108.26 | General |
| Category: Monoclonal Antibody | ||||||
| 10/04/2023 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: ONCOLOGY | ||||||
| 09/08/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $116.22 | General |
| Category: Oncology | ||||||
| 08/24/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $78.26 | General |
| Category: Monoclonal Antibody | ||||||
| 06/16/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $62.10 | General |
| Category: Oncology | ||||||
| 06/15/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $91.30 | General |
| Category: Monoclonal Antibody | ||||||
| 06/14/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $28.16 | General |
| 06/13/2023 | Genmab U.S., Inc. | — | Food and Beverage | In-kind items and services | $96.50 | General |
| 06/12/2023 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $137.77 | General |
| Category: Oncology | ||||||
| 04/12/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Oncology | ||||||
| 04/07/2023 | Kyowa Kirin Services Ltd | — | Travel and Lodging | Cash or cash equivalent | $296.80 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2, Open-Label Study of BGB-A317 in Patients With Relapsed or Refractory Mature T- and NK- Neoplasms | BeiGene, Ltd. | $650.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 229 | 658 | $246,491 | $64,043 |
| 2022 | 5 | 154 | 546 | $166,624 | $53,306 |
| 2021 | 5 | 209 | 711 | $203,252 | $65,041 |
| 2020 | 4 | 212 | 766 | $180,939 | $48,401 |
Total Patients
804
Total Services
2,681
Medicare Billing
$230,791
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 54 | 214 | $81,320 | $25,191 | 31.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 246 | $106,806 | $24,088 | 22.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 60 | $17,321 | $3,980 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 48 | $12,288 | $3,799 | 30.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 30 | $14,221 | $3,268 | 23.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $7,798 | $1,972 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 25 | $4,175 | $1,218 | 29.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 20 | 21 | $2,562 | $525.19 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 51 | 332 | $126,160 | $41,104 | 32.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 109 | $21,037 | $6,551 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 43 | $11,008 | $3,298 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 33 | 43 | $5,246 | $1,277 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 16 | 19 | $3,173 | $1,077 | 33.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 61 | 253 | $96,140 | $32,027 | 33.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 78 | 222 | $56,832 | $17,129 | 30.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 34 | 193 | $37,249 | $11,978 | 32.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 15 | 15 | $8,355 | $2,415 | 28.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 21 | 28 | $4,676 | $1,493 | 31.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 97 | 433 | $110,848 | $27,251 | 24.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 63 | 262 | $50,566 | $16,400 | 32.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 27 | 27 | $12,177 | $2,839 | 23.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 25 | 44 | $7,348 | $1,911 | 26.0% |
About Dr. Jasmine Zain, MD
Dr. Jasmine Zain, MD is a Hematology & Oncology healthcare provider based in Duarte, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043327075.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jasmine Zain, MD has received a total of $106,594 in payments from pharmaceutical and medical device companies, with $551.24 received in 2024. These payments were reported across 136 transactions from 25 companies. The most common payment nature is "Consulting Fee" ($46,848).
As a Medicare-enrolled provider, Zain has provided services to 804 Medicare beneficiaries, totaling 2,681 services with total Medicare billing of $230,791. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology
- Location Duarte, CA
- Active Since 08/24/2006
- Last Updated 06/27/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1043327075
Products in Payments
- POTELIGEO (Drug) $26,687
- ADCETRIS (Biological) $25,422
- CELLEX/XTS PHOTOPHERESIS SYSTEM (Device) $11,207
- SANCUSO (Drug) $8,000
- BELEODAQ (Drug) $4,659
- FARYDAK (Drug) $3,500
- Copiktra (Drug) $2,833
- Poteligeo (Drug) $2,419
- COPIKTRA (Drug) $2,152
- Revlimid (Drug) $214.56
- IMBRUVICA (Drug) $144.89
- MONJUVI (Drug) $137.77
- VALCHLOR (Drug) $119.86
- Yescarta (Drug) $119.58
- Epkinly (Drug) $116.22
- Ontak (Drug) $80.23
- BRUKINSA (Drug) $62.10
- Folotyn (Drug) $50.56
- VYXEOS (Drug) $25.28
- Imbruvica (Drug) $24.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Duarte
Dr. Christine Lovly, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $302,848
Hematology & Oncology $302,848
Robert Figlin, Md, MD
Hematology & Oncology — Payments: $234,191
Hematology & Oncology $234,191
Lihua Budde, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $223,363
Hematology & Oncology $223,363
Dr. Leslie Popplewell, M.d, M.D
Hematology & Oncology — Payments: $206,204
Hematology & Oncology $206,204
Mrs. Tanya Dorff, M.d, M.D
Hematology & Oncology — Payments: $198,135
Hematology & Oncology $198,135
Dr. Michael Rosenzweig, M.d, M.D
Hematology & Oncology — Payments: $136,718
Hematology & Oncology $136,718